Phibro Animal Health Corporation PAHC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.28% | 26.05% | 15.06% | 762.14% | 280.32% |
| Total Depreciation and Amortization | 5.83% | 7.57% | -1.33% | 11.38% | 42.49% |
| Total Amortization of Deferred Charges | 7.87% | 6.57% | 0.00% | 13.49% | 55.86% |
| Total Other Non-Cash Items | 76.97% | -133.86% | 792.25% | -36.17% | 151.28% |
| Change in Net Operating Assets | 32.05% | 31.52% | -416.91% | -41.77% | -1,813.02% |
| Cash from Operations | 180.39% | 13.27% | -62.45% | 529.13% | -26.30% |
| Capital Expenditure | -36.04% | -43.58% | -97.73% | -41.87% | -44.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 278.07% | 218.58% | 84.24% | -115.95% | -208.34% |
| Cash from Investing | 71.70% | -133.88% | 7.92% | 93.40% | -617.20% |
| Total Debt Issued | 73.26% | 39.45% | -9.88% | -87.11% | -84.83% |
| Total Debt Repaid | -131.11% | -27.05% | 35.00% | 61.91% | 88.85% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.16% | -0.06% | -0.06% | -0.08% | -0.08% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -134.49% | 79.20% | 92.86% | -106.87% | 155.95% |
| Foreign Exchange rate Adjustments | -447.66% | -61.91% | 290.50% | 87.22% | -85.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 198.71% | -15.55% | 91.71% | -213.43% | 125.19% |